ARCHIVES

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996